These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? Li X, Ketter TA, Frye MA. J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447 [Abstract] [Full Text] [Related]
7. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. Emrich HM, Dose M, von Zerssen D. J Affect Disord; 1985 May; 8(3):243-50. PubMed ID: 3160736 [Abstract] [Full Text] [Related]
11. Valproate in bipolar disorder: the Canadian perspective. Joffe RT. Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990 [Abstract] [Full Text] [Related]
12. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review. Emilien G, Maloteaux JM, Seghers A, Charles G. Arch Int Pharmacodyn Ther; 1995 Apr; 330(3):251-78. PubMed ID: 8836446 [Abstract] [Full Text] [Related]